Cboe US - Nasdaq Real Time Price USD

ARK Genomic Revolution ETF (ARKG)

19.80
-1.08
(-5.15%)
As of 12:00:00 PM EDT. Market Open.

Top 10 Holdings (60.37% of Total Assets)

SymbolCompany% Assets
RXRX
Recursion Pharmaceuticals, Inc. 7.96%
CRSP
CRISPR Therapeutics AG 7.80%
TWST
Twist Bioscience Corporation 7.70%
TEM
Tempus AI, Inc. 7.29%
ADPT
Adaptive Biotechnologies Corporation 5.53%
NTRA
Natera, Inc. 5.48%
GH
Guardant Health, Inc. 5.19%
CDNA
CareDx, Inc 4.66%
SDGR
Schrödinger, Inc. 4.43%
BEAM
Beam Therapeutics Inc. 4.33%

Sector Weightings

SectorARKG
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.99%
Bonds 0.00%

Equity Holdings

Price/Earnings 0
Price/Book 0.34
Price/Sales 0.15
Price/Cashflow 0
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.

ETF Overview

Category Health
Fund Family ARK ETF Trust
Net Assets 1.17B
YTD Daily Total Return -11.36%
Yield 0.00%
Legal Type Exchange Traded Fund

Related Tickers